The eradication of smallpox--an overview of the past, present, and futureDonald A Henderson
Johns Hopkins University, Center for Biosecurity, 621 East Pratt Street, Baltimore, MD 21202, USA
Vaccine 29:D7-9. 2011
..No less important are the growing number of multi-national programs whose foundations rest on the development of active case surveillance to measure achievement and to guide progress - poliomyelitis, measles, guinea worm, and rubella...
Bioterrorism as a public health threatD A Henderson
Johns Hopkins University, Baltimore, Maryland, USA
Emerg Infect Dis 4:488-92. 1998
..For longer-term solutions, the medical community must educate both the public and policy makers about bioterrorism and build a global consensus condemning its use...
Smallpox: clinical and epidemiologic featuresD A Henderson
Johns Hopkins University, Baltimore, MD, USA
Med Health R I 85:107-8. 2002
- Countering the posteradication threat of smallpox and polio
D A Henderson
The Johns Hopkins Center for Civilian Biodefense Studies, Baltimore, MD, USA
Clin Infect Dis 34:79-83. 2002
..In these countries, its continued use is advised because of its ability to induce intestinal immunity, its ability to spread to other susceptible household members and to protect them, its ease of administration, and its low cost...
- Recent events and observations pertaining to smallpox virus destruction in 2002
D A Henderson
The Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD 21202, USA
Clin Infect Dis 33:1057-9. 2001
....
- Smallpox virus destruction and the implications of a new vaccine
D A Henderson
Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA
Biosecur Bioterror 9:163-8. 2011
..This commentary provides approximations of these costs and the incremental contribution that a newly developed vaccine might make in terms of public health security...
- Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
D A Henderson
The Center for Civilian Biodefense Studies, School of Public Health, Johns Hopkins University, Baltimore, MD 21202, USA
JAMA 281:2127-37. 1999
..To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of smallpox as a biological weapon against a civilian population...
- Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
T V Inglesby
The Center for Civilian Biodefense Studies, School of Medicine, Johns Hopkins University, Baltimore, MD 21202, USA
JAMA 281:1735-45. 1999
..To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population...
- Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense
T V Inglesby
Center for Civilian Biodefense Studies, Johns Hopkins University Schools of Medicine, Baltimore, MD 21202, USA
JAMA 283:2281-90. 2000
..The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population...
- Public health and medical responses to the 1957-58 influenza pandemic
D A Henderson
Center for Biosecurity of the University of Pittsburgh Medical Center UPMC, Baltimore, Maryland 21202, USA
Biosecur Bioterror 7:265-73. 2009
..While it cannot be predicted with absolute certainty how the H1N1 pandemic might play out in the U.S. this fall, lessons from the 1957-58 influenza pandemic provide useful and practical insights for current planning and response efforts...
- Hemorrhagic fever viruses as biological weapons: medical and public health management
Luciana Borio
Johns Hopkins Center for Civilian Biodefense Strategies, Johns Hopkins Schools of Medicine and Public Health, 111 Market Pl, Suite 830, Baltimore, MD 21202, USA
JAMA 287:2391-405. 2002
..To develop consensus-based recommendations for measures to be taken by medical and public health professionals if hemorrhagic fever viruses (HFVs) are used as biological weapons against a civilian population...
- Return of epidemic dengue in the United States: implications for the public health practitioner
Nidhi Bouri
Center for Biosecurity of UPMC, Baltimore, MD 21205, USA
Public Health Rep 127:259-66. 2012
..Policy makers should understand the role of mosquito abatement and community engagement in the prevention and control of the disease...
- Improving performance of HVAC systems to reduce exposure to aerosolized infectious agents in buildings; recommendations to reduce risks posed by biological attacks
Penny J Hitchcock
Center for Biosecurity of UPMC, Baltimore, MD 21202, USA
Biosecur Bioterror 4:41-54. 2006
....
- Hospital preparedness for pandemic influenza
Eric Toner
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 4:207-17. 2006
- Disease mitigation measures in the control of pandemic influenza
Thomas V Inglesby
Center for Biosecurity of the University of Pittsburgh Medical Center, Baltimore, Maryland 21202, USA
Biosecur Bioterror 4:366-75. 2006
..Finally, the article summarizes the authors' judgments of the likely effectiveness and likely adverse consequences of the range of disease mitigation measures and suggests priorities and practical actions to be taken...
- Smallpox vaccination: a review, part I. Background, vaccination technique, normal vaccination and revaccination, and expected normal reactions
Vincent A Fulginiti
Department of Pediatrics, University of Arizona, Tucson, USA
Clin Infect Dis 37:241-50. 2003
..The characteristics of smallpox vaccine, the technique of administration, and the expected reactions to primary vaccination and revaccination are outlined in this article...
- Smallpox vaccination: a review, part II. Adverse events
Vincent A Fulginiti
Department of Pediatrics, University of Arizona, Tucson, USA
Clin Infect Dis 37:251-71. 2003
..Full understanding of the spectrum of adverse events and of their cause, frequency, identification, prevention, and treatment is imperative. This article describes known and suspected adverse events occurring after smallpox vaccination...
- The scientific response to a pandemic
Gigi Kwik Gronvall
Center for Biosecurity, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
PLoS Pathog 2:e9. 2006
- The dengue threat to the United States
Crystal Franco
Center for Biosecurity of UPMC, Baltimore, Maryland 21202, USA
Biosecur Bioterror 8:273-6. 2010
..The impact of dengue as a public health threat could be lessened through enhanced awareness and reporting of cases, increased support for vector surveillance and control programs, and a greater focus on vaccine development...
- Preventing the use of biological weapons: improving response should prevention fail
T V Inglesby
Center for Civilian Biodefense Studies, Johns Hopkins University School of Medicine, Baltimore, MD 21202, USA
Clin Infect Dis 30:926-9. 2000
....
- Eradication: lessons from the past
D A Henderson
Johns Hopkins University, Baltimore, MD, USA
Bull World Health Organ 76:17-21. 1998
..This approach, while interesting, fails to recognize many of the important lessons learned and their broad implications for contemporary disease control programmes worldwide...
- A conversation with D. A. Henderson. Interview by Jonathan M. Samet
D A Henderson
Epidemiology 16:266-9. 2005
- D.A. Henderson: acting globally, thinking locally
D A Henderson
Mol Interv 3:242-7. 2003
..Again and again, Henderson appears to have the knack for showing up in the right place at the right time with just the right idea...
- Bioweapons preparedness chief discusses priorities in world of 21st-century biology. Interview by Rebecca Voelker
D A Henderson
JAMA 287:573-5. 2002
- Diagnosis and management of smallpox
Joel G Breman
Fogarty International Center, National Institutes of Health, Bethesda, MD 20892, USA
N Engl J Med 346:1300-8. 2002
